Fri, Aug 1, 2014, 12:05 AM EDT - U.S. Markets open in 9 hrs 25 mins


% | $
Click the to save as a favorite.

Medivation, Inc. (MDVN) Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • hab124 hab124 Nov 4, 2012 5:11 PM Flag

    Tino just bought a huge block of MDVN...

    Medivation is a bio-pharmaceutical company based in San Francisco, California. It focuses in producing drugs for the treatment of serious diseases. MDVN collaborates with Astellas for the development and marketing of its prostate cancer drug.

    Columbus increased its shares in Medivation by 134% in the third quarter. The company now comprises 1.22% of the asset manager's total holdings. CCI initiated its position during the first quarter, and then drastically increased it by 259% in the second quarter.

    Recent reports show that the sales of Medivation's prostate cancer drug Xtandi have just surpassed analysts' expectations. The company's marketer reported third quarter revenue of $14 million even when the drug hit the market only in the middle of September. Thus, the quarterly revenue growth (yoy) is 171.61%. The stocks year-to-date performance has improved by about 106%.

74.23-2.02(-2.65%)Jul 31 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.